Cargando…

Performance of a Nomogram Based on the Integration of Inflammation Markers with Tumor Staging in Prognosis Prediction of Stage III Colorectal Cancer

INTRODUCTION: The aim of the present study was to evaluate a nomogram model for predicting the 5-year overall survival (OS) in lymph node-metastatic colorectal cancer (CRC) patients by combining inflammation markers with some traditional prognostic factors. METHODS: A total of 399 patients with stag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lin, Xiao, Jun, Li, Min-Zhe, Teng, Wen-Hao, Jia, Jing, Lin, Lu, Liu, Sheng, Ye, Xing-ming, Zang, Wei-Dong, Chen, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423355/ https://www.ncbi.nlm.nih.gov/pubmed/32821170 http://dx.doi.org/10.2147/CMAR.S263577

Ejemplares similares

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers
por: You, Weiqiang, et al.
Publicado: (2019)

Nomograms incorporated serum direct bilirubin level for predicting prognosis in stages II and III colorectal cancer after radical resection
por: Zhang, Qunfeng, et al.
Publicado: (2016)

A nomogram-based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer
por: Wang, Lingxiong, et al.
Publicado: (2021)

Immunological nomograms predicting prognosis and guiding adjuvant chemotherapy in stage II colorectal cancer
por: Feng, Yang, et al.
Publicado: (2019)

Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients
por: Yasui, Kohei, et al.
Publicado: (2020)

Prognostic scoring system based on eosinophil- and basophil-related markers for predicting the prognosis of patients with stage II and stage III colorectal cancer: a retrospective cohort study
por: Gao, Lijing, et al.
Publicado: (2023)

Nomogram for predicting overall survival time of patients with stage IV colorectal cancer
por: Lv, Min-Yi, et al.
Publicado: (2022)

Developing Preoperative Nomograms to Predict Any-Stage and Stage III-IV Endometriosis in Infertile Women
por: Guo, Zaixin, et al.
Publicado: (2020)

Establishment and validation of a novel nomogram incorporating clinicopathological parameters into the TNM staging system to predict prognosis for stage II colorectal cancer
por: Mo, Shaobo, et al.
Publicado: (2020)

A radiomics-based nomogram for preoperative T staging prediction of rectal cancer
por: Lin, Xue, et al.
Publicado: (2021)

Prognostic Value of E-cadherin-, CD44-, and MSH2-associated Nomograms in Patients With Stage II and III Colorectal Cancer
por: Qu, Jinmiao, et al.
Publicado: (2017)

Development and Validation of Nomograms to Predict Operative Link for Gastritis Assessment Any-Stage and Stages III–IV in the Chinese High-Risk Gastric Cancer Population
por: Wang, Song, et al.
Publicado: (2021)

Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer
por: Fu, Jinming, et al.
Publicado: (2023)

Development and validation of a collagen signature to predict the prognosis of patients with stage II/III colorectal cancer
por: Dong, Shumin, et al.
Publicado: (2023)

Postoperative circulating tumor DNA as markers of recurrence risk in stages II to III colorectal cancer
por: Chen, Gong, et al.
Publicado: (2021)

Integrated oxidative stress score for predicting prognosis in stage III gastric cancer undergoing surgery
por: Liu, Yu-hang, et al.
Publicado: (2023)

Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer
por: Snoeren, N, et al.
Publicado: (2013)

Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
por: Han, Xiaohong, et al.
Publicado: (2019)

Proposal of an automated tumor‐stromal ratio assessment algorithm and a nomogram for prognosis in early‐stage invasive breast cancer
por: Xu, Qian, et al.
Publicado: (2022)

Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma
por: Liu, Haohan, et al.
Publicado: (2020)

A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers
por: Han, Yang, et al.
Publicado: (2016)

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype
por: Kwon, Yujin, et al.
Publicado: (2017)

Intravascular emboli relates to immunosuppressive tumor microenvironment and predicts prognosis in stage III colorectal cancer
por: Song, Xiangping, et al.
Publicado: (2021)

Construction of Nomogram-Based Prediction Model for Clinical Prognosis of Patients with Stage II and III Colon Cancer Who Underwent Xelox Chemotherapy after Laparoscopic Radical Resection
por: Sun, Qiang, et al.
Publicado: (2022)

A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resection
por: Lin, Yanfei
Publicado: (2022)

Methylated septin 9 gene is an important prognostic marker in stage II and stage III colorectal cancer for evaluating local recurrence or distant metastasis after surgery
por: Huang, Mingliang, et al.
Publicado: (2022)

Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer
por: Zhang, Jieyun, et al.
Publicado: (2019)

Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer
por: Hector, S, et al.
Publicado: (2012)

HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet
por: Gambella, Alessandro, et al.
Publicado: (2022)

Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer
por: Toyokawa, Takahiro, et al.
Publicado: (2020)

Establishment and Validation of Nomogram Model Integrated With Inflammation-Based Factors for the Prognosis of Advanced Non-Small Cell Lung Cancer
por: Huang, Zhiliang, et al.
Publicado: (2020)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Low Expression of AGPAT5 Is Associated With Clinical Stage and Poor Prognosis in Colorectal Cancer and Contributes to Tumour Progression
por: Zang, Jia, et al.
Publicado: (2022)

Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging
por: Zang, Lele, et al.
Publicado: (2021)

Identification of a Novel Immune-Related CpG Methylation Signature to Predict Prognosis in Stage II/III Colorectal Cancer
por: Chen, Feng, et al.
Publicado: (2021)

The number of cycles of adjuvant chemotherapy in stage III and high-risk stage II rectal cancer: a nomogram and recursive partitioning analysis
por: Chen, Wei-Wei, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Predicting the Risk of Bell's Stage II/III Necrotizing Enterocolitis in Neonates Compared to Bell's Stage I
por: Song, Shuting, et al.
Publicado: (2022)

A Nomogram Model Involving Immunohistochemical Markers for Predicting the Recurrence of Stage I-II Endometrial Cancer
por: Jiang, Peng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sunlloe5upomnpd85pvv97stp0